Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

TAK1 inhibition promotes apoptosis in KRAS-dependent colon cancers.

Cell | Feb 17, 2012

Colon cancers frequently harbor KRAS mutations, yet only a subset of KRAS mutant colon cancer cell lines are dependent upon KRAS signaling for survival. In a screen for kinases that promote survival of KRAS-dependent colon cancer cells, we found that the TAK1 kinase (MAP3K7) is required for tumor cell viability. The induction of apoptosis by RNAi-mediated depletion or pharmacologic inhibition of TAK1 is linked to its suppression of hyperactivated Wnt signaling, evident in both endogenous and genetically reconstituted cells. In APC mutant/KRAS-dependent cells, KRAS stimulates BMP-7 secretion and BMP signaling, leading to TAK1 activation and enhancement of Wnt-dependent transcription. An in vitro-derived "TAK1 dependency signature" is enriched in primary human colon cancers with mutations in both APC and KRAS, suggesting potential clinical utility in stratifying patient populations. Together, these findings identify TAK1 inhibition as a potential therapeutic strategy for a treatment-refractory subset of colon cancers exhibiting aberrant KRAS and Wnt pathway activation.

Pubmed ID: 22341439 RIS Download

Mesh terms: Adenomatous Polyposis Coli Protein | Animals | Apoptosis | Bone Morphogenetic Proteins | Cell Line, Tumor | Cell Nucleus | Colonic Neoplasms | Gene Expression Profiling | Germ-Free Life | Humans | Intracellular Signaling Peptides and Proteins | Mice | Mutation | Neoplasm Transplantation | Proto-Oncogene Proteins | Proto-Oncogene Proteins p21(ras) | RNA Interference | Signal Transduction | Transcriptional Activation | Transplantation, Heterologous | Tumor Cells, Cultured | Wnt Signaling Pathway | beta Catenin | ras Proteins

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

Associated grants

  • Agency: NCI NIH HHS, Id: R01 CA109447-01
  • Agency: NCI NIH HHS, Id: R01 CA129933
  • Agency: NCI NIH HHS, Id: K99 CA149169
  • Agency: NCI NIH HHS, Id: R01 CA129933-01A1
  • Agency: NCI NIH HHS, Id: R00 CA149169
  • Agency: Howard Hughes Medical Institute, Id: R01 CA109447
  • Agency: NCI NIH HHS, Id: K99 CA149169-01
  • Agency: NCI NIH HHS, Id: K99 CA1-49169
  • Agency: NCI NIH HHS, Id:

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.